title: Is ondansetron a less effective antiemetic against moderately emetic as compared with highly emetic chemotherapy?
abstract: The severity of sickness in the first 5 days after cancer chemotherapy was compared in patients who had or had not received ondansetron 8 mg three times daily. Patients were divided into those having highly emetic chemotherapy, irrespective of gender and women having moderately emetic drugs. Ondansetron appeared to be more effective in the former group.
authors.affiliation: Northern Ireland Centre for Radiotherapy and Oncology, Belvoir Park Hospital, Belfast, Northern Ireland.
authors.forename: J W
authors.initials: JW
authors.lastname: Dundee
authors.forename: C M
authors.initials: CM
authors.lastname: McMillan
authors.forename: J
authors.initials: J
authors.lastname: Yang
authors.forename: P M
authors.initials: PM
authors.lastname: Wright
mesh_terms: D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D017294:Ondansetron; D012720:Severity of Illness Index; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents; D007093:Imidazoles; D017294:Ondansetron